Health & Safety Industry Today

Comprehensive Metabolic Panel Testing Market Size (USD 16.1 billion by 2032) Growing Rapidly with Recent Trends and Outlook

Factors such as the rising prevalence of chronic diseases and emphasis on early diagnosis and treatment are expected to drive the demand for CMP testing. The high prevalence of lifestyle-associated diseases, such as obesity, smoking, unhealthy eating habits, and lack of physical activity, are among the factors responsible for increasing the incidence of chronic diseases. The rise in the geriatric population is driving the market as they are more prone to diabetes and cardiovascular diseases.
Published 21 June 2024

Allied Market Research published a report, titled, โ€œComprehensive Metabolic Panel Testing Market by Test Type (Proteins, Electrolytes, Kidney Tests, Liver Tests, and Others), Disease Indication (Kidney Diseases, Liver Diseases, Diabetes, and Others), and End User (Hospitals, Diagnostic Laboratories, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032โ€ณ. According to the report, the global comprehensive metabolic panel testing industry generated $10.1 billion in 2022 and is anticipated to generate $16.1 billion by 2032, witnessing a CAGR of 4.8% from 2023 to 2032.

๐–๐ก๐š๐ญ ๐š๐ซ๐ž ๐ญ๐ก๐ž ๐ƒ๐ซ๐ข๐ฏ๐ข๐ง๐  ๐…๐š๐œ๐ญ๐จ๐ซ๐ฌ ๐Ž๐Ÿ ๐‚๐จ๐ฆ๐ฉ๐ซ๐ž๐ก๐ž๐ง๐ฌ๐ข๐ฏ๐ž ๐Œ๐ž๐ญ๐š๐›๐จ๐ฅ๐ข๐œ ๐๐š๐ง๐ž๐ฅ ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ?

Rise in prevalence of chronic diseases such as chronic kidney diseases, and diabetes, surge in geriatric population, and increase in advancements in diagnostic technologies are the factors that drive the growth of the global comprehensive metabolic panel testing market. However, lack of awareness about CMP testing in underdeveloped regions restricts market growth. Moreover, the high growth potential in emerging countries and rise in surge in trend towards point-of-care testing presents new opportunities in the coming years.

๐†๐ž๐ญ ๐…๐ฎ๐ฅ๐ฅ ๐๐ƒ๐… ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ (๐ˆ๐ง๐œ๐ฅ๐ฎ๐๐ข๐ง๐  ๐…๐ฎ๐ฅ๐ฅ ๐“๐Ž๐‚, ๐‹๐ข๐ฌ๐ญ ๐จ๐Ÿ ๐“๐š๐›๐ฅ๐ž๐ฌ & ๐…๐ข๐ ๐ฎ๐ซ๐ž๐ฌ, ๐‚๐ก๐š๐ซ๐ญ) ๐‚๐ฅ๐ข๐œ๐ค ๐‡๐ž๐ซ๐ž: https://www.alliedmarketresearch.com/request-sample/A269963

The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

๐‘๐ž๐œ๐ž๐ฌ๐ฌ๐ข๐จ๐ง ๐ˆ๐ฆ๐ฉ๐š๐œ๐ญ

  • During a recession, individuals and governments might tighten their budgets, leading to reduced healthcare spending. This could affect patientsโ€™ ability to access and afford comprehensive metabolic panel testing, potentially leading to decreased demand for comprehensive metabolic panel testing products.
  • However, the surge in prevalence of chronic diseases and rise in technological advancements. This could boost the need for comprehensive metabolic panel testing that is experiencing a moderately positive impact from the global recession.

๐“๐จ๐ฉ ๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ ๐จ๐Ÿ ๐‚๐จ๐ฆ๐ฉ๐ซ๐ž๐ก๐ž๐ง๐ฌ๐ข๐ฏ๐ž ๐Œ๐ž๐ญ๐š๐›๐จ๐ฅ๐ข๐œ ๐๐š๐ง๐ž๐ฅ ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ

ยทย ย ย ย ย ย ย ย Quest Diagnostics

ยทย ย ย ย ย ย ย ย Laboratory Corporation of America Holdings

ยทย ย ย ย ย ย ย ย F. Hoffmann-La Roche Ltd.

ยทย ย ย ย ย ย ย ย Blueprint Genetics

ยทย ย ย ย ย ย ย ย ARUP Laboratories,

ยทย ย ย ย ย ย ย ย Walk-In Lab, LLC.

ยทย ย ย ย ย ย ย ย Applied InGENuity Diagnostics

ยทย ย ย ย ย ย ย ย Scion Lab Services, LLC

ยทย ย ย ย ย ย ย ย Baptist Health

ยทย ย ย ย ย ย ย ย My Care Labs

๐‚๐จ๐ฆ๐ฉ๐ซ๐ž๐ก๐ž๐ง๐ฌ๐ข๐ฏ๐ž ๐Œ๐ž๐ญ๐š๐›๐จ๐ฅ๐ข๐œ ๐๐š๐ง๐ž๐ฅ ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง ๐œ๐š๐ง ๐›๐ž ๐๐จ๐ง๐ž ๐›๐š๐ฌ๐ž๐ ๐จ๐ง ๐ฌ๐ž๐ฏ๐ž๐ซ๐š๐ฅ ๐Ÿ๐š๐œ๐ญ๐จ๐ซ๐ฌ, ๐ข๐ง๐œ๐ฅ๐ฎ๐๐ข๐ง๐ :

By test type, the kidney tests segment held the largest market share in 2022, accounting for more than one-fourth of the global comprehensive metabolic panel testing market revenue, and is estimated to maintain its leadership status throughout the forecast period. This is attributed to kidney diseases such as chronic kidney disease (CKD) which have become more prevalent due to factors such as aging populations, diabetes, and hypertension thereby driving the demand for CMP testing.

By disease indication, the kidney diseases segment held the largest market share in 2022, accounting for more than one-third of the global comprehensive metabolic panel testing market revenue and is estimated to maintain its leadership status throughout the forecast period. This is attributed to emphasis on early detection and proactive management of kidney diseases fuels the demand for routine monitoring through CMP testing.

By end user, the diagnostic laboratories segment accounted for the largest share in 2022, contributing to nearly half of global comprehensive metabolic panel testing market revenue, and is projected to maintain its lead position during the forecast period. This is attributed to their advanced infrastructure, comprehensive testing capabilities, trained personnel, accessibility, high throughput, integration into healthcare networks, technological advancements, and patient-focused services.

By region, North America held the largest market share in terms of revenue in 2022, accounting for more than two-fifths of the global comprehensive metabolic panel testing market revenue and is likely to dominate the market during the forecast period. This is attributed to its well-developed healthcare infrastructure, technological advancements in testing methodologies, and growing emphasis on preventive healthcare practices in North America.

However, the Asia-Pacific region is expected to witness the fastest CAGR of 5.9% from 2023 to 2032. This is attributed to rise in the prevalence of chronic diseases, including diabetes, cardiovascular disorders, and obesity, increase in awareness of the importance of routine health check-ups and preventive healthcare practices is driving the demand for diagnostic services,

๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/A269963

๐Ž๐ฎ๐ซ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐’๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง ๐๐ซ๐จ๐ฏ๐ข๐๐ž๐ฌ ๐˜๐จ๐ฎ ๐€๐ง๐ฌ๐ฐ๐ž๐ซ ๐ญ๐จ ๐๐ž๐ฅ๐จ๐ฐ ๐Œ๐ž๐ง๐ญ๐ข๐จ๐ง๐ž๐ ๐๐ฎ๐ž๐ฌ๐ญ๐ข๐จ๐ง:

โ€ข Which are the driving factors responsible for the growth of market?

โ€ข Which are the roadblock factors of this market?

โ€ข What are the new opportunities, by which market will grow in coming years?

โ€ข What are the trends of this market?

โ€ข Which are main factors responsible for new product launch?

โ€ข How big is the global & regional market in terms of revenue, sales and production?

โ€ข How far will the market grow in forecast period in terms of revenue, sales and production?

โ€ข Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?

โ€ข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?

โ€ข Which region has more opportunities?

Our Market Research Solution Provides You Answer to Below Mentioned Question:

โ€ข Which are the driving factors responsible for the growth of market?

โ€ข Which are the roadblock factors of this market?

โ€ข What are the new opportunities, by which market will grow in coming years?

โ€ข What are the trends of this market?

โ€ข Which are main factors responsible for new product launch?

โ€ข How big is the global & regional market in terms of revenue, sales and production?

โ€ข How far will the market grow in forecast period in terms of revenue, sales and production?

โ€ข Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?

โ€ข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?

โ€ข Which region has more opportunities?

By Region Outlook

ยทย ย ย ย ย ย ย ย North America

(U.S., Canada, Mexico)

ยทย ย ย ย ย ย ย ย Europe

(Germany, France, UK, Italy, Spain, Rest of Europe)

ยทย ย ย ย ย ย ย ย Asia-Pacific

(Japan, China, India, Rest of Asia-Pacific)

ยทย ย ย ย ย ย ย ย LAMEA

(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022

help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โ€œMarket Research Reportsโ€ and โ€œBusiness Intelligence Solutions.โ€ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Other Industry News

Ready to start publishing

Sign Up today!